77 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 19328820 | Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof | AEDER, SEAN E | 1642 | Non-Final OA | Sep 15, 2025 |
| 19285781 | COMPOSITIONS AND METHODS OF TREATING LUPUS NEPHRITIS | WEN, SHARON X | 1641 | Non-Final OA | Jul 30, 2025 |
| 19210983 | CDK INHIBITORS | RODRIGUEZ, RAYNA B | 1628 | Non-Final OA | May 16, 2025 |
| 19210611 | CDK INHIBITORS | RODRIGUEZ, RAYNA B | 1628 | Non-Final OA | May 16, 2025 |
| 19210825 | CDK INHIBITORS | RODRIGUEZ, RAYNA B | 1628 | Non-Final OA | May 16, 2025 |
| 18961292 | ESTIMATION OF QUANTITATIVE SYSTEMS PHARMACOLOGY (QSP) TREATMENT EFFECT PARAMETERS USING DEEP LEARNING | VAN DUZER, ALEXIS KIM | 3682 | Non-Final OA | Nov 26, 2024 |
| 18908575 | INCISION GUIDE TOOL FOR OCULAR DEVICE IMPLANTATION AND METHODS OF USE | TANNER, JOCELIN C | 3771 | Non-Final OA | Oct 07, 2024 |
| 18883384 | DEEP CONVOLUTIONAL NEURAL NETWORKS FOR TUMOR SEGMENTATION WITH POSITRON EMISSION TOMOGRAPHY | CWERN, JONATHAN | 3797 | Non-Final OA | Sep 12, 2024 |
| 18828915 | PHARMACEUTICAL ASSET TRACKING | BURSUM, KIMBERLY SUZANNE | 3627 | Non-Final OA | Sep 09, 2024 |
| 18752501 | MULTI-VECTOR RECOMBINASE MEDIATED CASSETTE EXCHANGE | KONOPKA, CATHERINE ANNE | 1635 | Final Rejection | Jun 24, 2024 |
| 18743859 | METHOD AND APPARATUS FOR USING OMALIZUMAB | BOUCHELLE, LAURA A | 3783 | Final Rejection | Jun 14, 2024 |
| 18669218 | SYNTHETIC CONTROLS FOR IMMUNOHISTOCHEMISTRY | NGUYEN, NAM P | 1678 | Final Rejection | May 20, 2024 |
| 18664892 | DEEP LEARNING FOR MODELING DISEASE PROGRESSION | JAMES, DOMINIQUE NICOLE | 2666 | Non-Final OA | May 15, 2024 |
| 18627251 | BIOLOGICAL CONTEXT FOR ANALYZING WHOLE SLIDE IMAGES | ROSARIO, DENNIS | 2676 | Non-Final OA | Apr 04, 2024 |
| 18536174 | HIERARCHICAL WORKFLOW FOR GENERATING ANNOTATED TRAINING DATA FOR MACHINE LEARNING ENABLED IMAGE SEGMENTATION | TSAI, TSUNG YIN | 2656 | Non-Final OA | Dec 11, 2023 |
| 18523284 | HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS | SHIAO, REI TSANG | 1691 | Non-Final OA | Nov 29, 2023 |
| 18516417 | TUMOR IMMUNOPHENOTYPING BASED ON SPATIAL DISTRIBUTION ANALYSIS | HOANG, HAN DINH | 2661 | Non-Final OA | Nov 21, 2023 |
| 18516406 | DETECTING TERTIARY LYMPHOID STRUCTURES IN DIGITAL PATHOLOGY IMAGES | HOANG, HAN DINH | 2661 | Non-Final OA | Nov 21, 2023 |
| 18482237 | TREATMENT OUTCOME PREDICTION FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION USING BASELINE CHARACTERISTICS | WINDSOR, COURTNEY J | 2661 | Final Rejection | Oct 06, 2023 |
| 18377039 | Traceable Medical Vials | AFRIFA-KYEI, ANTHONY D | 2686 | Non-Final OA | Oct 05, 2023 |
| 18469957 | METHODS OF TREATING LUNG CANCER WITH A PD-1 AXIS BINDING ANTAGONIST, AN ANTIMETABOLITE, AND A PLATINUM AGENT | TAYLOR, LIA ELAN | 1641 | Non-Final OA | Sep 19, 2023 |
| 18464580 | ANTI-KLK7 ANTIBODIES, ANTI-KLK5 ANTIBODIES, MULTISPECIFIC ANTI-KLK5/KLK7 ANTIBODIES, AND METHODS OF USE | SHUPE, ELIZABETH A | 1643 | Non-Final OA | Sep 11, 2023 |
| 18463585 | ATTENTION-BASED MULTIPLE INSTANCE LEARNING FOR WHOLE SLIDE IMAGES | TRAN, DUY ANH | 2674 | Final Rejection | Sep 08, 2023 |
| 18449800 | TREATMENT OF BREAST CANCER USING COMBINATION THERAPIES COMPRISING GDC-9545 AND GDC-0077 | RZECZYCKI, PHILLIP MATTHEW | 1625 | Non-Final OA | Aug 15, 2023 |
| 18449807 | TREATMENT OF BREAST CANCER USING COMBINATION THERAPIES COMPRISING GDC-9545 AND IPATASERTIB | CHAO, ALLEN | 1622 | Non-Final OA | Aug 15, 2023 |
| 18364185 | ANTI-INTERLEUKIN-33 ANTIBODIES AND USES THEREOF | ALLEN, MARIANNE P | 1647 | Final Rejection | Aug 02, 2023 |
| 18357772 | PATHOLOGICAL RESPONSE CALCULATION AND ASSESSMENT TOOL | WALLACE, JOHN R | 2682 | Non-Final OA | Jul 24, 2023 |
| 18349015 | Methods and Systems for Determining Kinetic Parameters | GABEL, GAILENE | 1678 | Non-Final OA | Jul 07, 2023 |
| 18346128 | ANTI-CD8 ANTIBODIES AND USES THEREOF | SLOUP IV, RUDOLPH EDWARD | 1645 | Non-Final OA | Jun 30, 2023 |
| 18210604 | ASSEMBLY OF BISPECIFIC ANTIBODIES | HUYNH, PHUONG N | 1641 | Final Rejection | Jun 15, 2023 |
| 18334531 | METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND TIGIT INHIBITORS | OUSPENSKI, ILIA I | 1644 | Non-Final OA | Jun 14, 2023 |
| 18332324 | HIGH-THROUGHPUT METHODS FOR PREPARING LIPID NANOPARTICLES AND USES THEREOF | SHOMER, ISAAC | 1612 | Final Rejection | Jun 09, 2023 |
| 18206853 | METHODS FOR DETERMINING THE RELATIVE DISTRIBUTION OF GLUCURONIDATION, IDURONIDATION, AND GALACTURONIDATION OF POLYPEPTIDES | SIMMONS, VALERIE MICHELLE | 1758 | Non-Final OA | Jun 07, 2023 |
| 18329972 | THERAPEUTIC AND DIAGNOSTIC METHODS FOR IL-33-MEDIATED DISORDERS | SITTON, JEHANNE SOUAYA | 1682 | Non-Final OA | Jun 06, 2023 |
| 18328305 | MULTIMODAL PREDICTION OF GEOGRAPHIC ATROPHY GROWTH RATE | BITAR, NANCY | 2664 | Non-Final OA | Jun 02, 2023 |
| 18204281 | INDUCTIVE HEAT STERILIZING SYSTEMS, DEVICES, AND METHODS | LEE, AHAM NMN | 1758 | Non-Final OA | May 31, 2023 |
| 18323240 | PYRROLIDINE DERIVATIVES AND METHODS OF USE | BELL, SARA ELIZABETH | 1625 | Non-Final OA | May 24, 2023 |
| 18321199 | CONTAINED SINGLE-USE POWDER INDUCTION SYSTEM AND METHOD OF USE | BHATIA, ANSHU | 1774 | Non-Final OA | May 22, 2023 |
| 18315450 | SMALL PARTS CLEANING APPARATUS AND METHODS OF USE | LEE, KEVIN G | 1711 | Non-Final OA | May 10, 2023 |
| 18310913 | PROTAC ANTIBODY CONJUGATES AND METHODS OF USE | VAN DRUFF, SYDNEY | 1643 | Final Rejection | May 02, 2023 |
| 18297546 | 8-(AZETIDIN-1-YL)-[1,2,4]TRIAZOLO[1,5-A]PYRIDINYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | JARRELL, NOBLE E | 1699 | Final Rejection | Apr 07, 2023 |
| 18295539 | DOSING FOR TREATMENT WITH ANTI-FCRH5/ANTI-CD3 BISPECIFIC ANTIBODIES | ALLEN, MARIANNE P | 1647 | Non-Final OA | Apr 04, 2023 |
| 18194542 | HYDROXYPROPYL METHYL CELLULOSE DERIVATIVES TO STABILIZE POLYPEPTIDES | KNIGHT, SAMANTHA JO | 1614 | Non-Final OA | Mar 31, 2023 |
| 18190697 | THERMAL SEPARATOR APPARATUS FOR FLASK STIRRER AND METHOD OF USE | JARRETT, LORE RAMILLANO | 1797 | Non-Final OA | Mar 27, 2023 |
| 18124096 | PURIFICATION OF MULTISPECIFIC ANTIBODIES | BRISTOL, LYNN ANNE | 1643 | Non-Final OA | Mar 21, 2023 |
| 18173002 | ASSAYS AND REAGENTS FOR CHARACTERIZATION OF MHCI PEPTIDE BINDING | LUSI, ELLIS FOLLETT | 1677 | Non-Final OA | Feb 22, 2023 |
| 18163819 | DIAGNOSTIC AND THERAPEUTIC METHODS FOR LYMPHOMA | CASH, KAILEY ELIZABETH | 1683 | Non-Final OA | Feb 02, 2023 |
| 18156744 | ANTIBODY-CONJUGATED CHEMICAL INDUCERS OF DEGRADATION OF BRM AND METHODS THEREOF | VAN DRUFF, SYDNEY | 1643 | Non-Final OA | Jan 19, 2023 |
| 18004550 | Anti-Notch2 Antibodies and Methods of Use | HADDAD, MAHER M | 1641 | Final Rejection | Jan 06, 2023 |
| 17999799 | BELVARAFENIB FOR USE IN CANCER TREATMENT | BELL, SARA ELIZABETH | 1625 | Non-Final OA | Nov 23, 2022 |
| 18048986 | METHODS OF USING ANTI-CD79B IMMUNOCONJUGATES | GODDARD, LAURA B | 1642 | Non-Final OA | Oct 24, 2022 |
| 18046865 | METHODS FOR ASSAYING T-CELL DEPENDENT BISPECIFIC ANTIBODIES | SKELDING, ZACHARY S | 1644 | Non-Final OA | Oct 14, 2022 |
| 17964325 | METHOD FOR MEDIUM TREATMENT BEFORE INOCULATION | MOSS, NATALIE M | 1653 | Non-Final OA | Oct 12, 2022 |
| 17937102 | THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER | AEDER, SEAN E | 1642 | Non-Final OA | Sep 30, 2022 |
| 17947820 | USE OF GENETIC ALGORITHMS TO DETERMINE A MODEL TO IDENTITY SAMPLE PROPERTIES BASED ON RAMAN SPECTRA | THOMPSON, MILANA KAYE | 1687 | Non-Final OA | Sep 19, 2022 |
| 17822746 | EFFICIENT GENOME EDITING IN PRIMARY MYELOID CELLS | VANHORN, ABIGAIL LOUISE | 1636 | Non-Final OA | Aug 26, 2022 |
| 17842715 | CULTURE SYSTEM AND METHODS FOR IMPROVED MODELING OF NEUROLOGICAL CONDITIONS | TRAN, KHOA NHAT | 1632 | Final Rejection | Jun 16, 2022 |
| 17806252 | INHALER DEVICES, MEDICATION FORMULATIONS USED THEREWITH AND METHODS OF MANUFACTURE | RUDDIE, ELLIOT S | 3785 | Non-Final OA | Jun 09, 2022 |
| 17833719 | METHODS, SYSTEMS, AND TOOLS FOR LONGEVITY-RELATED APPLICATIONS | BEVERIDGE, CONNOR HAMMOND | 1687 | Non-Final OA | Jun 06, 2022 |
| 17587797 | MULTIPOLE MOMENT BASED COARSE GRAINED REPRESENTATION OF ANTIBODY ELECTROSTATICS | AUGER, NOAH ANDREW | 1687 | Final Rejection | Jan 28, 2022 |
| 17629327 | DETECTING NEURALLY PROGRAMMED TUMORS USING EXPRESSION DATA | MINCHELLA, KAITLYN L | 1685 | Final Rejection | Jan 21, 2022 |
| 17542138 | METHOD FOR REGENERATION OF AN OVERLOAD CHROMATOGRAPHY COLUMN | KIM, YUNSOO | 1641 | Non-Final OA | Dec 03, 2021 |
| 17513710 | PURIFICATION PLATFORMS FOR OBTAINING PHARMACEUTICAL COMPOSITIONS HAVING A REDUCED HYDROLYTIC ENZYME ACTIVITY RATE | SUNSHINE, HANNAH LOUISE | 1647 | Non-Final OA | Oct 28, 2021 |
| 17503122 | ANTIBODY POTENCY ASSAY | EVANS, CHRISTOPHER RYAN | 1677 | Non-Final OA | Oct 15, 2021 |
| 17473401 | TREATMENT OF CANCER WITH HER2XCD3 BISPECIFIC ANTIBODIES IN COMBINATION WITH ANTI-HER2 MAB | CHASE, CAROL ANN | 1646 | Final Rejection | Sep 13, 2021 |
| 17469533 | METHODS FOR DETECTING AND QUANTIFYING MEMBRANE-ASSOCIATED PROTEINS | COOK, LISA V | 1642 | Final Rejection | Sep 08, 2021 |
| 17378651 | ATTENTION-BASED NEURAL NETWORK TO PREDICT PEPTIDE BINDING, PRESENTATION, AND IMMUNOGENICITY | BAILEY, STEVEN WILLIAM | 1687 | Non-Final OA | Jul 16, 2021 |
| 17351451 | TARGETED INTEGRATION OF NUCLEIC ACIDS | GODDARD, LAURA B | 1642 | Final Rejection | Jun 18, 2021 |
| 17343543 | MODIFIED ANTIBODY FCS AND METHODS OF USE | GUSTILO, ESTELLA M | 1646 | Non-Final OA | Jun 09, 2021 |
| 17229746 | COPPER LOSS MITIGATION | MIANO, JOSEPH PAUL | 1631 | Non-Final OA | Apr 13, 2021 |
| 17275609 | PYRIMIDINYL-HETEROARYLOXY-NAPHTHYL COMPOUNDS AND METHODS OF USE | LEE, CHIHYI NMN | 1628 | Final Rejection | Mar 11, 2021 |
| 17249457 | CARBOXAMIDE AND SULFONAMIDE DERIVATIVES USEFUL AS TEAD MODULATORS | KENYON, JOHN S | 1625 | Final Rejection | Mar 02, 2021 |
| 17172528 | CELL CULTURE STRATEGIES FOR MODULATING PROTEIN GLYCOSYLATION | AFREMOVA, VERA | 1653 | Final Rejection | Feb 10, 2021 |
| 17075238 | OVERLOAD AND ELUTE CHROMATOGRAPHY | STONEBRAKER, ALYSSA RAE | 1642 | Non-Final OA | Oct 20, 2020 |
| 16653167 | METHODS OF TREATING RESIDUAL BREAST CANCER WITH TRASTUZUMAB EMTANSINE | SKOKO III, JOHN JOSEPH | 1643 | Non-Final OA | Oct 15, 2019 |
| 16221369 | PURIFICATION OF MULTISPECIFIC ANTIBODIES | HALVORSON, MARK | 1646 | Non-Final OA | Dec 14, 2018 |
| 16185369 | METHODS OF DECREASING TRISULFIDE BONDS DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | BELYAVSKYI, MICHAIL A | 1644 | Final Rejection | Nov 09, 2018 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial